The Algerian public pharmaceutical group SAIDAL achieved a record turnover of 44.04 billion Algerian dinars in 2025, equivalent to around $326 million, an increase of 98.43% compared to the previous year. These results were presented at the general assembly held on June 29, 2026. This growth is explained by an increase in sales. The group...
Trending
- AFIS 2026: BRVM advocates for increased integration of African capital markets
- InsurTech in Africa: Over $300 million invested in five years
- Senegal, banks: APBEF-SN adopts a new visual identity
- Allegria Ntumba Luaba appointed Director of Business Development at AfCRA
- Luanda Biennial: Félix Tshisekedi defends DRC’s sovereignty over its water resources
- Daily news from African financial markets
- AFINHAB: 100 billion FCFA of Social Bonds to expand household access to mortgage credit
- Cameroon: GECAM President Involved in Land Dispute That Undermines Private Investment
